A Case of Ferumoxytol (Feraheme(®)) Prompting Critical Modification to Our Patient Prebreast Magnetic Resonance Imaging Questionnaire

Apparent gadolinium-based contrast enhancement was seen on precontrast-enhanced images on two breast magnetic resonance imaging (MRI) for a patient done 1 week apart. This was caused by ferumoxytol, which is used to treat some anemias. Such nongadolinium-based therapeutics exhibiting unintended MRI...

Descripción completa

Detalles Bibliográficos
Autores principales: Samreen, Naziya, Bhatt, Asha A, Glockner, James, Lee, Christine U
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Scientific Scholar 2019
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6702869/
https://www.ncbi.nlm.nih.gov/pubmed/31448157
http://dx.doi.org/10.25259/JCIS-9-6
_version_ 1783445317101813760
author Samreen, Naziya
Bhatt, Asha A
Glockner, James
Lee, Christine U
author_facet Samreen, Naziya
Bhatt, Asha A
Glockner, James
Lee, Christine U
author_sort Samreen, Naziya
collection PubMed
description Apparent gadolinium-based contrast enhancement was seen on precontrast-enhanced images on two breast magnetic resonance imaging (MRI) for a patient done 1 week apart. This was caused by ferumoxytol, which is used to treat some anemias. Such nongadolinium-based therapeutics exhibiting unintended MRI contrast-like properties preclude assessment of enhancement kinetics in breast MRI significantly limiting diagnostic interpretation. This case prompted a group discussion and subsequent modification to the patient breast MRI safety screening questionnaire at our institution.
format Online
Article
Text
id pubmed-6702869
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher Scientific Scholar
record_format MEDLINE/PubMed
spelling pubmed-67028692019-08-23 A Case of Ferumoxytol (Feraheme(®)) Prompting Critical Modification to Our Patient Prebreast Magnetic Resonance Imaging Questionnaire Samreen, Naziya Bhatt, Asha A Glockner, James Lee, Christine U J Clin Imaging Sci Case Report Apparent gadolinium-based contrast enhancement was seen on precontrast-enhanced images on two breast magnetic resonance imaging (MRI) for a patient done 1 week apart. This was caused by ferumoxytol, which is used to treat some anemias. Such nongadolinium-based therapeutics exhibiting unintended MRI contrast-like properties preclude assessment of enhancement kinetics in breast MRI significantly limiting diagnostic interpretation. This case prompted a group discussion and subsequent modification to the patient breast MRI safety screening questionnaire at our institution. Scientific Scholar 2019-03-28 /pmc/articles/PMC6702869/ /pubmed/31448157 http://dx.doi.org/10.25259/JCIS-9-6 Text en © 2019 - Published by Scientific Scholar on behalf of Journal of Clinical Imaging Science https://creativecommons.org/licenses/by-nc-sa/4.0 This is an open-access article distributed under the terms of the Creative Commons Attribution-Non Commercial-Share Alike 4.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as the author is credited and the new creations are licensed under the identical terms.
spellingShingle Case Report
Samreen, Naziya
Bhatt, Asha A
Glockner, James
Lee, Christine U
A Case of Ferumoxytol (Feraheme(®)) Prompting Critical Modification to Our Patient Prebreast Magnetic Resonance Imaging Questionnaire
title A Case of Ferumoxytol (Feraheme(®)) Prompting Critical Modification to Our Patient Prebreast Magnetic Resonance Imaging Questionnaire
title_full A Case of Ferumoxytol (Feraheme(®)) Prompting Critical Modification to Our Patient Prebreast Magnetic Resonance Imaging Questionnaire
title_fullStr A Case of Ferumoxytol (Feraheme(®)) Prompting Critical Modification to Our Patient Prebreast Magnetic Resonance Imaging Questionnaire
title_full_unstemmed A Case of Ferumoxytol (Feraheme(®)) Prompting Critical Modification to Our Patient Prebreast Magnetic Resonance Imaging Questionnaire
title_short A Case of Ferumoxytol (Feraheme(®)) Prompting Critical Modification to Our Patient Prebreast Magnetic Resonance Imaging Questionnaire
title_sort case of ferumoxytol (feraheme(®)) prompting critical modification to our patient prebreast magnetic resonance imaging questionnaire
topic Case Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6702869/
https://www.ncbi.nlm.nih.gov/pubmed/31448157
http://dx.doi.org/10.25259/JCIS-9-6
work_keys_str_mv AT samreennaziya acaseofferumoxytolferahemepromptingcriticalmodificationtoourpatientprebreastmagneticresonanceimagingquestionnaire
AT bhattashaa acaseofferumoxytolferahemepromptingcriticalmodificationtoourpatientprebreastmagneticresonanceimagingquestionnaire
AT glocknerjames acaseofferumoxytolferahemepromptingcriticalmodificationtoourpatientprebreastmagneticresonanceimagingquestionnaire
AT leechristineu acaseofferumoxytolferahemepromptingcriticalmodificationtoourpatientprebreastmagneticresonanceimagingquestionnaire
AT samreennaziya caseofferumoxytolferahemepromptingcriticalmodificationtoourpatientprebreastmagneticresonanceimagingquestionnaire
AT bhattashaa caseofferumoxytolferahemepromptingcriticalmodificationtoourpatientprebreastmagneticresonanceimagingquestionnaire
AT glocknerjames caseofferumoxytolferahemepromptingcriticalmodificationtoourpatientprebreastmagneticresonanceimagingquestionnaire
AT leechristineu caseofferumoxytolferahemepromptingcriticalmodificationtoourpatientprebreastmagneticresonanceimagingquestionnaire

Ejemplares similares